← All Topics / ade

FDA ADE reports for Cefovecin (third-generation cephalosporin antibiotic (injectable, dogs & cats)) — total reports, species & reaction breakdown

ade_cefovecin_adverse_events

ade en 2026-07-22

Cefovecin — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Cefovecin is a third-generation cephalosporin antibiotic (injectable, dogs & cats).

Total reports

Cefovecin: 9343

Reports by species (top entries)

  • Cat 5650
  • Dog 2820
  • Human 29
  • Guinea Pig 3
  • Ferret 2
  • Other 2

Top reported reactions (VEDDRA terms, top entries)

  • Lethargy (see also Central nervous system depression in 'Neurological') 1755
  • Vomiting 1319
  • Anorexia 1213
  • Death 1054
  • Death by euthanasia 754
  • Diarrhoea 687
  • Weight loss 659
  • Fever 600
  • Lack of efficacy - NOS 592
  • Other abnormal test result NOS 588

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM ADE), pulled 2026-07-22